RadNet Reports Q1 2026 Earnings: Revenue Beats Estimates Despite EPS Miss
RadNet, Inc. (RDNT) held its First Quarter 2026 earnings conference call on May 11, 2026, to discuss financial results and operational updates. The company reported revenue of $575.63 million, representing a 22.11% year-over-year increase and beating analyst estimates by $20.93 million. However, earnings per share (EPS) came in at -$0.28, missing expectations by $0.09. Key executives, including Chairman and CEO Howard Berger, Executive VP and CFO Mark Stolper, and Digital Health leaders Cornelis Wesdorp and Sham Sokka, participated in the call. They addressed questions from analysts representing major financial institutions such as Jefferies, Barclays, and Raymond James. The discussion likely covered the performance of RadNet's core imaging services and the progress of its Digital Health operating segment. This event highlights the company's continued revenue growth trajectory despite short-term profitability challenges, providing investors with insights into strategic developments and future outlooks for the medical imaging and digital health sectors.
Wire timeline
RadNet Reports Q1 2026 Earnings: Revenue Beats Estimates Despite EPS Miss
RadNet, Inc. (RDNT) held its First Quarter 2026 earnings conference call on May 11, 2026, to discuss financial results and operational updates. The company reported revenue of $575.63 million, representing a 22.11% year-over-year increase and beating analyst estimates by $20.93 million. However, earnings per share (EPS) came in at -$0.28, missing expectations by $0.09. Key executives, including Chairman and CEO Howard Berger, Executive VP and CFO Mark Stolper, and Digital Health leaders Cornelis Wesdorp and Sham Sokka, participated in the call. They addressed questions from analysts representing major financial institutions such as Jefferies, Barclays, and Raymond James. The discussion likely covered the performance of RadNet's core imaging services and the progress of its Digital Health operating segment. This event highlights the company's continued revenue growth trajectory despite short-term profitability challenges, providing investors with insights into strategic developments and future outlooks for the medical imaging and digital health sectors.
All Articles on Seeking Alpha